Relx Plc (NYSE:RELX – Get Free Report) has been assigned an average rating of “Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company.
A number of equities analysts have recently weighed in on the stock. Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday, March 14th. The Goldman Sachs Group assumed coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a “buy” rating on the stock. StockNews.com downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th.
View Our Latest Analysis on Relx
Institutional Investors Weigh In On Relx
Relx Trading Down 0.4%
NYSE RELX opened at $53.84 on Monday. Relx has a 1-year low of $42.77 and a 1-year high of $55.21. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a market capitalization of $99.65 billion, a PE ratio of 28.95, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. The firm’s fifty day simple moving average is $50.59 and its 200-day simple moving average is $48.72.
Relx Increases Dividend
The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This is a boost from Relx’s previous semi-annual dividend of $0.23. This represents a yield of 1.6%. Relx’s dividend payout ratio is currently 59.68%.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- EV Stocks and How to Profit from Them
- Constellation Powers Up With Reinforced AI Data Center Strategy
- What is Short Interest? How to Use It
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Stock Sentiment Analysis: How it Works
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.